Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition.
Weintraub Y, Collen LV, Hussey S, Mitrova K, Machta JS, Kang B, Granot M, D'Arcangelo G, Spencer EA, Kolho KL, Yeh PJ, Sladek M, Scarallo L, Palomino L, Afzal NA, de Laffolie J, Miele E, Bramuzzo M, Olén O, Russell RK, Rohani P, Tzivinikos C, Urlep D, van Rheenen PF, de Ridder L, Yogev D, Schneider AM, Cohen S, Garcia-Romero R, Dipasquale V, Uhlig HH, Shouval DS. Weintraub Y, et al. Among authors: russell rk. Inflamm Bowel Dis. 2025 Jan 15:izae302. doi: 10.1093/ibd/izae302. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 39813158
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study.
Stein R, Turner D, Hussey S, Kawasmi A, Ledder O, Levine J, Markowitz J, Matar M, Orlanski-Meyer E, Russell RK, Shaoul R, Yerushalmy-Feler A, Mould DR, Conrad MA. Stein R, et al. Among authors: russell rk. Aliment Pharmacol Ther. 2025 Jan 15. doi: 10.1111/apt.18484. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 39812549
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D. Atia O, et al. Among authors: russell rk. Lancet Gastroenterol Hepatol. 2025 Jan 6:S2468-1253(24)00319-4. doi: 10.1016/S2468-1253(24)00319-4. Online ahead of print. Lancet Gastroenterol Hepatol. 2025. PMID: 39788134
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group.
van Rheenen PF, Kolho KL, Russell RK, Aloi M, Deganello A, Hussey S, Junge N, De Laffolie J, Deneau MR, Fitzpatrick E, Griffiths AM, Hojsak I, Nicastro E, Nita A, Pakarinen M, Ricciuto A, de Ridder L, Sonzogni A, Tenca A, Samyn M, Indolfi G. van Rheenen PF, et al. Among authors: russell rk. J Pediatr Gastroenterol Nutr. 2024 Dec 31. doi: 10.1002/jpn3.12378. Online ahead of print. J Pediatr Gastroenterol Nutr. 2024. PMID: 39741383
Gender and Intersecting Barriers and Facilitators to Access the HIV Cascade of Care in Manitoba, Canada, Before and During the COVID-19 Pandemic: A Qualitative Study.
Villacis-Alvarez E, Sobie C, Maier K, Lavallee M, Daniels C, Pashe H, Baliddawa J, Daniels N, Murdock R, Russell R, Dan C, Woodhouse F, Cusson S, Patrick L, Schenkels M, Payne M, Kasper K, MacKenzie LJ, Ireland L, Templeton K, Deering K, Haworth-Brockman M, Keynan Y, Rueda ZV. Villacis-Alvarez E, et al. Among authors: russell r. Trop Med Infect Dis. 2024 Nov 25;9(12):287. doi: 10.3390/tropicalmed9120287. Trop Med Infect Dis. 2024. PMID: 39728814 Free PMC article.
4,415 results